{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:45:24Z","timestamp":1792856724874,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12017-010-8126-6","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T07:22:39Z","timestamp":1279092159000},"page":"37-43","source":"Crossref","is-referenced-by-count":62,"title":["Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer\u2019s Disease as Identified by Biomarkers"],"prefix":"10.1007","volume":"13","author":[{"given":"Thomas J.","family":"Montine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Peskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen S.","family":"Montine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"8126_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., et al. (2008). Frequent amyloid deposition without significant cognitive impairment among the elderly. Archives of Neurology, 65, 1509\u20131517.","journal-title":"Archives of Neurology"},{"key":"8126_CR2","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., et al. (2005). Molecular, structural, and functional characterization of Alzheimer\u2019s disease: Evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25, 7709\u20137717.","journal-title":"Journal of Neuroscience"},{"key":"8126_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-4580(95)02002-0","volume":"17","author":"S Craft","year":"1996","unstructured":"Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., et al. (1996). Memory improvement following induced hyperinsulinemia in Alzheimer\u2019s disease. Neurobiology of Aging, 17, 123\u2013130.","journal-title":"Neurobiology of Aging"},{"key":"8126_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., et al. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans. Annals of Neurology, 59, 512\u2013519.","journal-title":"Annals of Neurology"},{"key":"8126_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007). Cerebrospinal fluid tau\/beta-amyloid (42) ratio as a prediction of cognitive decline in non demented older adults. Archives of Neurology, 64, 343\u2013349.","journal-title":"Archives of Neurology"},{"key":"8126_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189\u2013198.","journal-title":"Journal of Psychiatric Research"},{"key":"8126_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","volume":"297","author":"C Hesse","year":"2001","unstructured":"Hesse, C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., et al. (2001). Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neuroscience Letters, 297, 187\u2013190.","journal-title":"Neuroscience Letters"},{"key":"8126_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e3181b01077","volume":"73","author":"D Iacono","year":"2009","unstructured":"Iacono, D., Markesbery, W. R., Gross, M., Pletnikova, O., Rudow, G., Zandi, P., et al. (2009). The Nun study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology, 73, 665\u2013673.","journal-title":"Neurology"},{"key":"8126_CR9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000107699","volume":"4","author":"MC Irizarry","year":"2007","unstructured":"Irizarry, M. C., Yao, Y., Hyman, B. T., Growdon, J. H., & Pratico, D. (2007). Plasma F2A isoprostane levels in Alzheimer\u2019s and Parkinson\u2019s disease. Neuro-degenerative Diseases, 4, 403\u2013405.","journal-title":"Neuro-degenerative Diseases"},{"key":"8126_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","volume":"69","author":"G Li","year":"2007","unstructured":"Li, G., Sokal, I., Quinn, J. F., Leverenz, J. B., Brodey, M., Schellenberg, G. D., et al. (2007). CSF tau\/A\u03b242 ratio for increased risk of mild cognitive impairment: A follow-up study. Neurology, 69, 631\u2013639.","journal-title":"Neurology"},{"key":"8126_CR11","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/jnr.21346","volume":"85","author":"MA Lovell","year":"2007","unstructured":"Lovell, M. A., & Markesbery, W. R. (2007). Oxidative damage in mild cognitive impairment and early Alzheimer\u2019s disease. Journal of Neuroscience Research, 85, 3036\u20133040.","journal-title":"Journal of Neuroscience Research"},{"key":"8126_CR12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","volume":"68","author":"WR Markesbery","year":"2009","unstructured":"Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009). Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology, 68, 816\u2013822.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8126_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jchromb.2005.03.037","volume":"827","author":"D Milatovic","year":"2005","unstructured":"Milatovic, D., VanRollins, M., Li, K., Montine, K. S., & Montine, T. J. (2005). Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 827, 88\u201393.","journal-title":"Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"8126_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., et al. (2006). [11C]PIB in a non demented population: Potential antecedent marker of Alzheimer disease. Neurology, 67, 446\u2013452.","journal-title":"Neurology"},{"key":"8126_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.410440322","volume":"44","author":"TJ Montine","year":"1998","unstructured":"Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J., II. (1998). Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer\u2019s disease. Annals of Neurology, 44, 410\u2013413.","journal-title":"Annals of Neurology"},{"key":"8126_CR16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/WNL.53.7.1495","volume":"53","author":"TJ Montine","year":"1999","unstructured":"Montine, T. J., Sidell, K. R., Crews, B. C., Markesbery, W. R., Marnett, L. J., Roberts, L. J., II et al. (1999). Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology, 53, 1495\u20131498.","journal-title":"Neurology"},{"key":"8126_CR17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5858\/2001-125-0510-CFATAF","volume":"125","author":"TJ Montine","year":"2001","unstructured":"Montine, T. J., Kaye, J. A., Montine, K. S., McFarland, L., Morrow, J. D., & Quinn, J. F. (2001). Cerebrospinal fluid A\u03b242, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Archives of Pathology and Laboratory Medicine, 125, 510\u2013512.","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"8126_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.10272","volume":"52","author":"TJ Montine","year":"2002","unstructured":"Montine, T. J., Quinn, J. F., Milatovic, D., Silbert, L. C., Dang, T., Sanchez, S., et al. (2002). Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer\u2019s disease. Annals of Neurology, 52, 175\u2013179.","journal-title":"Annals of Neurology"},{"key":"8126_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/ars.2005.7.269","volume":"7","author":"TJ Montine","year":"2005","unstructured":"Montine, T. J., Montine, K. S., McMahan, W., Markesbery, W. R., Quinn, J. F., & Morrow, J. D. (2005). F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants & Redox Signaling, 7, 269\u2013275.","journal-title":"Antioxidants & Redox Signaling"},{"key":"8126_CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12031-007-0044-1","volume":"33","author":"TJ Montine","year":"2007","unstructured":"Montine, T. J., Quinn, J., Kaye, J., & Morrow, J. D. (2007). F(2)-isoprostanes as biomarkers of late-onset Alzheimer\u2019s disease. Journal of Molecular Neuroscience, 33, 114\u2013119.","journal-title":"Journal of Molecular Neuroscience"},{"key":"8126_CR21","doi-asserted-by":"crossref","unstructured":"Montine, T. J., Shi, M., Quinn, J. F., Peskind, E. R., Craft, S., Ginghina C., Chung K. A., Kim, H., Galasko, D. R., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Zhang, J. (2010). CSF A\u03b242 and tau in Parkinson\u2019s disease with cognitive impairment. Movement disorders in press.","DOI":"10.1002\/mds.23287"},{"key":"8126_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000289224","volume":"7","author":"EJ Mufson","year":"2010","unstructured":"Mufson, E. J., & Leurgans, S. (2010). Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer\u2019s disease. Neuro-degenerative Diseases, 7, 139\u2013142.","journal-title":"Neuro-degenerative Diseases"},{"key":"8126_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.wad.0000194014.43575.fd","volume":"19","author":"ER Peskind","year":"2005","unstructured":"Peskind, E. R., Riekse, R., Quinn, J. F., Kaye, J., Clark, C. M., Farlow, M. R., et al. (2005). Safety and acceptability of the research lumbar puncture. Alzheimer Disease and Associated Disorders, 19, 220\u2013225.","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"8126_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1092852900016151","volume":"13","author":"RC Petersen","year":"2008","unstructured":"Petersen, R. C., & Negash, S. (2008). Mild cognitive impairment: An overview. CNS spectrums, 13, 45\u201353.","journal-title":"CNS spectrums"},{"key":"8126_CR25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.20318","volume":"57","author":"H Petrovitch","year":"2005","unstructured":"Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., et al. (2005). AD lesions and infarcts in demented and non-demented Japanese-American men. Annals of Neurology, 57, 98\u2013103.","journal-title":"Annals of Neurology"},{"key":"8126_CR26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9","volume":"48","author":"D Pratico","year":"2000","unstructured":"Pratico, D., Clark, C. M., Lee, V. M., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000). Increased 8, 12-iso-iPF2alpha-VI in Alzheimer\u2019s disease: Correlation of a noninvasive index of lipid peroxidation with disease severity. Annals of Neurology, 48, 809\u2013812.","journal-title":"Annals of Neurology"},{"key":"8126_CR27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","volume":"59","author":"D Pratico","year":"2002","unstructured":"Pratico, D., Clark, C. M., Liun, F., Rokach, J., Lee, V. Y., & Trojanowski, J. Q. (2002). Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Archives of Neurology, 59, 972\u2013976.","journal-title":"Archives of Neurology"},{"key":"8126_CR28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","volume":"30","author":"JL Price","year":"2009","unstructured":"Price, J. L., McKeel, D. W. Jr., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., et al. (2009). Neuropathology of non demented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging, 30, 1026\u20131036.","journal-title":"Neurobiology of Aging"},{"key":"8126_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2004-6110","volume":"6","author":"JF Quinn","year":"2004","unstructured":"Quinn, J. F., Montine, K. S., Moore, M., Morrow, J. D., Kaye, J. A., & Montine, T. J. (2004). Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease, 6, 93\u201397.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8126_CR30","first-page":"134","volume-title":"The Halstead-Reitan neuropsychological test battery. The neuropsychology handbook behavioral and clinical perspectives","author":"RM Reitan","year":"1986","unstructured":"Reitan, R. M., & Wolfson, D. (1986). The Halstead-Reitan neuropsychological test battery. The neuropsychology handbook behavioral and clinical perspectives (pp. 134\u2013160). New York: Springer Publishing Co."},{"key":"8126_CR31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneurol.2010.19","volume":"67","author":"DM Rentz","year":"2010","unstructured":"Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., et al. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67, 353\u2013364.","journal-title":"Annals of Neurology"},{"key":"8126_CR32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","volume":"28","author":"LJ Roberts","year":"2000","unstructured":"Roberts, L. J., & Morrow, J. D. (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine, 28, 505\u2013513.","journal-title":"Free Radical Biology and Medicine"},{"key":"8126_CR33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.55.3.370","volume":"55","author":"FA Schmitt","year":"2000","unstructured":"Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000). \u201cPreclinical\u201d AD revisited: neuropathology of cognitively normal older adults. Neurology, 55, 370\u2013376.","journal-title":"Neurology"},{"key":"8126_CR34","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","volume":"88","author":"CD Smith","year":"1991","unstructured":"Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 88, 10540\u201310543.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8126_CR35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.21208","volume":"62","author":"JA Sonnen","year":"2007","unstructured":"Sonnen, J. A., Larson, E. B., Crane, P. K., Haneuse, S., Li, G., Schellenberg, G. D., et al. (2007). Pathological correlates of dementia in a longitudinal, population-based sample of aging. Annals of Neurology, 62, 406\u2013413.","journal-title":"Annals of Neurology"},{"key":"8126_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2008.04.022","volume":"45","author":"JA Sonnen","year":"2008","unstructured":"Sonnen, J. A., Breitner, J. C., Lovell, M. A., Markesbery, W. R., Quinn, J. F., & Montine, T. J. (2008a). Free radical-mediated damage to brain in Alzheimer\u2019s disease and its transgenic mouse models. Free Radical Biology and Medicine, 45, 219\u2013230.","journal-title":"Free Radical Biology and Medicine"},{"key":"8126_CR37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S1474-4422(08)70162-5","volume":"7","author":"JA Sonnen","year":"2008","unstructured":"Sonnen, J. A., Montine, K. S., Quinn, J. F., Kaye, J. A., Breitner, J. C., & Montine, T. J. (2008b). Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol, 7, 704\u2013714.","journal-title":"Lancet Neurol"},{"key":"8126_CR38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ana.21508","volume":"65","author":"JA Sonnen","year":"2009","unstructured":"Sonnen, J. A., Larson, E. B., Gray, S. L., Wilson, A., Kohama, S. G., Crane, P. K., et al. (2009). Free radical damage to cerebral cortex in Alzheimer\u2019s disease, microvascular brain injury, and smoking. Annals of Neurology, 65, 226\u2013229.","journal-title":"Annals of Neurology"},{"key":"8126_CR39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0361-9230(01)00450-6","volume":"54","author":"EE Tuppo","year":"2001","unstructured":"Tuppo, E. E., Forman, L. J., Spur, B. W., Chan-Ting, R. E., Chopra, A., & Cavalieri, T. A. (2001). Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer\u2019s disease. Brain Research Bulletin, 54, 565\u2013568.","journal-title":"Brain Research Bulletin"},{"key":"8126_CR40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ageing\/afm120","volume":"36","author":"SL Tyas","year":"2007","unstructured":"Tyas, S. L., Snowdon, D. A., Desrosiers, M. F., Riley, K. P., & Markesbery, W. R. (2007). Healthy ageing in the Nun study: Definition and neuropathologic correlates. Age and Ageing, 36, 650\u2013655.","journal-title":"Age and Ageing"},{"key":"8126_CR41","volume-title":"Paragraph recall as well as category fluency and letter fluency Weschler memory scale","author":"W Wechsler","year":"1987","unstructured":"Wechsler, W. (1987). Paragraph recall as well as category fluency and letter fluency Weschler memory scale. San Antonio, TX: The Psychological Corporation."}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-010-8126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-010-8126-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-010-8126-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T10:48:30Z","timestamp":1635677310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-010-8126-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["8126"],"URL":"https:\/\/doi.org\/10.1007\/s12017-010-8126-6","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}